TAYD - テイラ―・デバイス （Taylor Devices Inc.）

Taylor Devices press release (TAYD): Q3 GAAP EPS of $0.47.Revenue of $9.89M (+61.1% Y/Y).

Taylor Devices specializes in shock-absorbing devices for construction and aerospace uses, among others. See here for the business and TAYD stock outlook.

Taylor Devices is a well-established company with a high level of expertise in the shock and vibration control field. See why we are a hold on TAYD stock.

Taylor Devices press release (NASDAQ:TAYD): Q2 GAAP EPS of $0.45.Revenue of $10.5M (+35.5% Y/Y).

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH ) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ: QTNT ) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ: BXRX ) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ: PALI ) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection. Nuwellis, Inc. (NASDAQ: NUWE ) shares climbed 40.5% to $12.88. Nuwellis announced an exclusive U.S. license and distribution agreement for SeaStar Medical Holding’s Selective Cytopheretic Device (SCD) for acute kidney injury (AKI) in children.

Taylor Devices specializes in shock-absorbing devices for construction and aerospace uses, among others. See here for the business and TAYD stock outlook.

Taylor Devices is a well-established company with a high level of expertise in the shock and vibration control field. See why we are a hold on TAYD stock.

Taylor Devices press release (NASDAQ:TAYD): Q2 GAAP EPS of $0.45.Revenue of $10.5M (+35.5% Y/Y).

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH ) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ: QTNT ) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ: BXRX ) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ: PALI ) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection. Nuwellis, Inc. (NASDAQ: NUWE ) shares climbed 40.5% to $12.88. Nuwellis announced an exclusive U.S. license and distribution agreement for SeaStar Medical Holding’s Selective Cytopheretic Device (SCD) for acute kidney injury (AKI) in children.

Gainers:Expion360 Inc. (XPON) +24%.Taylor Devices, Inc

Taylor Devices is a well-established company with a high level of expertise in the shock and vibration control field. See why we are a hold on TAYD stock.

Taylor Devices press release (NASDAQ:TAYD): Q2 GAAP EPS of $0.45.Revenue of $10.5M (+35.5% Y/Y).

Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH ) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. Quotient Limited (NASDAQ: QTNT ) shares jumped 124% to $0.5382 after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasdaq Global Market. Baudax Bio, Inc. (NASDAQ: BXRX ) climbed 65.8% to $3.8150 after gaining over 5% on Wednesday. Baudax Bio recently announced initiation of a Phase II clinical trial evaluationg BX1000 in patients undergoing surgery. Palisade Bio, Inc. (NASDAQ: PALI ) gained 52% to $2.76. Palisade Bio recently provided an update on its U.S. Phase 2 study evaluating LB1148 for the reduction in intra-abdominal adhesions in subjects following elective bowel resection. Nuwellis, Inc. (NASDAQ: NUWE ) shares climbed 40.5% to $12.88. Nuwellis announced an exclusive U.S. license and distribution agreement for SeaStar Medical Holding’s Selective Cytopheretic Device (SCD) for acute kidney injury (AKI) in children.

Gainers:Expion360 Inc. (XPON) +24%.Taylor Devices, Inc

Taylor Devices Inc (NASDAQ: TAYD ) reported second-quarter FY23 sales growth of 35% year-on-year, to $10.49 million. Net earnings for Q2 totaled $1.6 million versus $0.7 million … Full story available on Benzinga.com